Larisa V. Gubareva

Overview

Best Publications

• Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

  Seema Jain;Lyn Finelli;Michael W. Shaw;Stephen Lindstrom

  4742
  Citations

• Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans

  Rebecca J. Garten;C. Todd Davis;Colin A. Russell;Colin A. Russell;Bo Shu

  3408
  Citations

• Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

  Anthony E Fiore;Alicia Fry;David Shay;Larisa Gubareva

  1059
  Citations

• Influenza virus neuraminidase inhibitors

  Larisa V Gubareva;Laurent Kaiser;Frederick G Hayden

  1020
  Citations

• Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009

  Vivek Shinde;Carolyn B Bridges;Timothy M Uyeki;Bo Shu

  958
  Citations

• Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States

  Nila J. Dharan;Larisa V. Gubareva;John J. Meyer;Margaret Okomo-Adhiambo

  773
  Citations

• Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide

  Varough M. Deyde;Xiyan Xu;Rick A. Bright;Michael Shaw

  695
  Citations

• Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021.

  Sonja J Olsen;Amber K Winn;Alicia P Budd;Mila M Prill

  678
  Citations

• Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

  Tiffany G. Sheu;Varough M. Deyde;Margaret Okomo-Adhiambo;Rebecca J. Garten

  625
  Citations

• Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus

  Larisa V. Gubareva;Mikhail N. Matrosovich;Malcolm K. Brenner;Richard C. Bethell

  520
  Citations

• Inhaled zanamivir for the prevention of influenza in families

  Frederick G. Hayden;Larisa V. Gubareva;Arnold S. Monto;Thomas C. Klein

  500
  Citations

• Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses.

  Laurent Kaiser;R. Scott Fritz;Stephen E. Straus;Larisa Gubareva

  462
  Citations

• Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.

  Larisa V. Gubareva;Laurent Kaiser;Mikhail N. Matrosovich;Mikhail N. Matrosovich;Yee Soo-Hoo

  393
  Citations

• Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.

  L V Gubareva;M J Robinson;R C Bethell;R G Webster

  309
  Citations

• Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.

  Michael G. Ison;Larisa V. Gubareva;Robert L. Atmar;John Treanor

  302
  Citations

• Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.

  Vasiliy P. Mishin;Frederick G. Hayden;Larisa V. Gubareva

  292
  Citations

• Influenza Activity — United States, 2015–16 Season and Composition of the 2016–17 Influenza Vaccine

  Stacy L Davlin;Lenee Blanton;Krista Kniss;Desiree Mustaquim

  290
  Citations

• Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection

  Michael P. Malakhov;Laura M. Aschenbrenner;Donald F. Smee;Miles K. Wandersee

  288
  Citations

• Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants

  Larisa V. Gubareva;Robert G. Webster;Robert G. Webster;Frederick G. Hayden

  287
  Citations

• Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.

  Unknown

  287
  Citations

• Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.

  L. Gubareva;M. Okomo-Adhiambo;V. Deyde;A. M. Fry

  280
  Citations

• Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives.

  Aeron C Hurt;Tawee Chotpitayasunondh;Nancy J Cox;Rod Daniels

  262
  Citations

• Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.

  L V Gubareva;R Bethell;G J Hart;K G Murti

  261
  Citations

• Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.

  Ha T Nguyen;Alicia M Fry;Larisa V Gubareva

  248
  Citations

• Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient.

  David M Weinstock;Larisa V Gubareva;Gianna Zuccotti

  243
  Citations

• Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015

  Adam Meijer;Helena Rebelo-de-Andrade;Helena Rebelo-de-Andrade;Vanessa Correia;Vanessa Correia;Terry Besselaar

  241
  Citations

• Characterization of Influenza A/HongKong/156/97 (H5N1) Virus in a Mouse Model and Protective Effect of Zanamivir on H5N1 Infection in Mice

  Larisa V. Gubareva;Jonathan A. McCullers;Richard C. Bethell;Robert G. Webster

  216
  Citations

• Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.

  Larisa V. Gubareva;Robert G. Webster;Robert G. Webster;Frederick G. Hayden

  207
  Citations

• Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

  Alicia M Fry;Doli Goswami;Kamrun Nahar;Amina Tahia Sharmin

  174
  Citations

• Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.

  Luis Barroso;John Treanor;Larisa Gubareva;Frederick G Hayden

  169
  Citations

• Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014

  Unknown

  167
  Citations

• Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.

  Donald F. Smee;Kevin W. Bailey;Min-Hui Wong;Barry R. O’Keefe

  148
  Citations

• Recovery of a Multidrug-Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/I223R Mutation from a Child after Prolonged Treatment with Oseltamivir

  Ha T. Nguyen;Alicia M. Fry;P. Ann Loveless;Alexander I. Klimov

  144
  Citations

• In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication

  Warren M. Kati;Debra Montgomery;Robert Carrick;Larisa Gubareva

  142
  Citations